• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

CDC Forecast Gives Dates When COVID-19 Hospitalizations Could Peak This Season

October 29, 2024 by Deborah Bloomfield

The nights are drawing in, the weather’s turning chilly, and spooky season is upon us – the Northern Hemisphere is fully in the grip of fall. But as well as all the cozy vibes and holiday fun, this time of year unfortunately brings with it a wave of respiratory viruses. The Centers for Disease Control and Prevention (CDC) just released its latest outlook for flu, COVID-19, and respiratory syncytial virus (RSV), so what can we expect?

These three viruses together have been dubbed by some a “tripledemic”. A winter increase in cases is to be expected, but the levels and severity do vary year by year. 

Advertisement

This year, according to the CDC, “As of mid-October, overall US respiratory disease activity remained low.” Despite a recent increase in COVID-19 cases caused by the newest kid variant on the block XEC, overall test positivity rates, ER visits, and hospitalizations were on a downward trend. Flu and RSV activity also remains low for now, so if a tripledemic is coming, the US isn’t seeing it quite yet. 

That doesn’t mean that authorities can take their eyes off the ball, and close monitoring will continue, but the overall summary of the outlook is not particularly pessimistic: “CDC continues to expect that the 2024-2025 fall and winter virus season will likely have a similar or lower number of combined peak hospitalizations from flu, COVID-19, and RSV compared to last season.”

As to exactly when the peak might happen for COVID-19, the CDC has a couple of hypothetical scenarios based on SARS-CoV-2 activity during the summer.

In scenario A, the peak of COVID-19 summer activity does not hit until after the fall/winter respiratory season has already started. This leads to a peak of COVID-19 hospitalizations in December.

Advertisement

Scenario B, on the other hand, has summer COVID-19 activity peaking earlier, with a smaller second wave of infections arriving in mid-January. 

In reality, the agency says that “we expect the upcoming season to be more similar to Scenario A, with a winter peak that is higher than the summer/fall peak before it.” That’s because the COVID-19 summer wave seems to have peaked in early August, and population immunity may not be as high as we might have forecast coming into the winter season. 

Therefore, we might expect to see the most COVID-19-related hospitalizations in late December and early January – though, of course, this is just an estimate. 

While the predictions suggest we could be in for a milder season than 2023-24, that doesn’t mean that flu, RSV, and COVID-19 do not continue to pose a real threat – particularly to the elderly, the very young, and those with compromised immune systems. Vaccination is the best line of defense we have, and thankfully is now available for all three of these viruses.

Advertisement

Flu and COVID-19 vaccines are currently recommended by the CDC for everyone aged 6 months and older. RSV vaccination is available for select groups who are most at risk from the virus:

  • Adults aged 75 and over
  • Adults aged 60-75 who are at increased risk – speak to your doctor or pharmacist to find out if you’re in this category
  • Pregnant people between 32 and 36 weeks of gestation
  • Babies – either when no vaccine was given during the pregnancy, or where a baby aged 8-19 months is considered at increased risk

And throughout the fall and winter, it’s always worth remembering the simple things everyone can do to help stop the spread of infection: hand washing, staying home when you’re sick, and wearing a face covering in enclosed or crowded spaces. 

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Near Space Labs closes $13M Series A to send more Earth imaging robots to the stratosphere
  2. US stock futures lead Asia lower, dollar gains on yen
  3. A Weight-Loss Drug Has Been Approved For Obese Children 12 And Up
  4. Ancient Egyptian Scribes Had The Same Bad Posture As You

Source Link: CDC Forecast Gives Dates When COVID-19 Hospitalizations Could Peak This Season

Filed Under: News

Primary Sidebar

  • Experiment Appears To Confirm Mind-Bending Penrose-Terrell Effect Predicted 66 Years Ago
  • After 100 Years, Scientists Finally Find The Genetic Mutation That Makes Cats Orange
  • Nootropics: Do “Smart Drugs” Really Make You Smarter?
  • Better Solutions To Black Hole Collisions Thanks To 6-Dimensional Donuts
  • Weather Forecast On Titan: Methane Clouds With A Chance Of Showers, According To JWST
  • Tokyo Is The Biggest City In The World… Or Is It?
  • After 21 Years, Voyager 1 Fires Its Thrusters Again Thanks To Long-Distance Servicing
  • Men Have Double The Chance Of Dying From “Broken Heart Syndrome” That Women Do
  • “Copy” Of Magna Carta Bought For $27.50 Turns Out To Be A 1300 CE Original
  • Long-Lived, Carnivorous, And Freaky: Watch These Snails Lay Eggs Through Their Necks
  • This Radio Announcer Test From The 1920s Would Befuddle Even The Best English Speakers
  • Health Secretary Robert F. Kennedy Jr Says People Shouldn’t Take Medical Advice From Him
  • Tiger And Vet Survive Triple Root Canal
  • Why Are Pencils Hexagonal?
  • Why You Shouldn’t Drink Your Own Urine (Can’t Believe We Have To Write This)
  • There Is Something Odd Going On Inside The Moon
  • New Species Of Three-Eyed “Sea Moth” Hunted In Earth’s Oceans 506 Million Years Ago
  • For The First Time, Common Hospital “Superbug” Found To Break Down Medical Plastics
  • First Ever Visible Green Aurorae Seen On Mars
  • New Species Of “Heavenly” Tiny Metallic Poison Dart Frog Discovered In The Amazon
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version